Impaired c-Met Receptor Degradation Mediated by MET Exon 14 Mutations in Non-Small-Cell Lung Cancer

被引：34
|
作者：
Awad, Mark M. [1 ]
机构：
[1] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 08期
关键词：
SARCOMATOID CARCINOMA; AMPLIFICATION; CRIZOTINIB; GEFITINIB; PATIENT; CBL; UBIQUITINATION; RESPONSIVENESS; CHEMOTHERAPY; SENSITIVITY;
D O I：
10.1200/JCO.2015.64.2777
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：879 / +
页数：5
相关论文
共 50 条
  • [1] MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
    Awad, Mark M.
    Oxnard, Geoffrey R.
    Jackman, David M.
    Savukoski, Daniel O.
    Hall, Dimity
    Shivdasani, Priyanka
    Heng, Jennifer C.
    Dahlberg, Suzanne E.
    Anne, Pasi A. J.
    Verma, Suman
    Christensen, James
    Hammerman, Peter S.
    Sholl, Lynette M.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07) : 721 - +
  • [2] Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
    Paik, Paul K.
    Felip, Enriqueta
    Veillon, Remi
    Sakai, Hiroshi
    Cortot, Alexis B.
    Garassino, Marina C.
    Mazieres, Julien
    Viteri, Santiago
    Senellart, Helene
    Van Meerbeeck, Jan
    Raskin, Jo
    Reinmuth, Niels
    Conte, Pierfranco
    Kowalski, Dariusz
    Cho, Byoung Chul
    Patel, Jyoti D.
    Horn, Leora
    Griesinger, Frank
    Han, Ji-Youn
    Kim, Young-Chul
    Chang, Gee-Chen
    Tsai, Chen-Liang
    Yang, James C. -H.
    Chen, Yuh-Min
    Smit, Egbert F.
    van der Wekken, Anthonie J.
    Kato, Terufumi
    Juraeva, Dilafruz
    Stroh, Christopher
    Bruns, Rolf
    Straub, Josef
    Johne, Andreas
    Scheele, Juergen
    Heymach, John V.
    Le, Xiuning
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (10): : 931 - 943
  • [3] Tepotinib for advanced non-small-cell lung cancer with MET exon 14 skipping mutations
    Blaszkowska, M.
    Specht-Szwoch, Z.
    Dziadziuszko, R.
    ESMO OPEN, 2022, 7 (02)
  • [4] Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations
    Digumarthy, Subba R.
    Mendoza, Dexter P.
    Zhang, Eric W.
    Lennerz, Jochen K.
    Heist, Rebecca S.
    CANCERS, 2019, 11 (12)
  • [5] Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer
    Wolf, Juergen
    Seto, Takashi
    Han, Ji-Youn
    Reguart, Noemi
    Garon, Edward B.
    Groen, Harry J. M.
    Tan, Daniel S. W.
    Hida, Toyoaki
    de Jonge, Maja
    Orlov, Sergey V.
    Smit, Egbert F.
    Souquet, Pierre-Jean
    Vansteenkiste, Johan
    Hochmair, Maximilian
    Felip, Enriqueta
    Nishio, Makoto
    Thomas, Michael
    Ohashi, Kadoaki
    Toyozawa, Ryo
    Overbeck, Tobias R.
    de Marinis, Filippo
    Kim, Tae-Min
    Laack, Eckart
    Robeva, Anna
    Le Mouhaer, Sylvie
    Waldron-Lynch, Maeve
    Sankaran, Banu
    Balbin, O. Alejandro
    Cui, Xiaoming
    Giovannini, Monica
    Akimov, Mikhail
    Heist, Rebecca S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (10): : 944 - 957
  • [6] MET Exon 14 Skipping Mutations Essential Considerations for Current Management of Non-Small-Cell Lung Cancer
    Davies, Kurtis D.
    Ritterhouse, Lauren L.
    Snow, Anthony N.
    Sidiropoulos, Nikoletta
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (08): : 841 - 843
  • [7] Coexistence of MET exon 14 mutations with EGFR mutations in non-small cell lung cancer
    Li, Wen-Feng
    Kang, Jin
    Zhang, Xu-Chao
    Jian, Su
    Chen, Huajun
    Wang, Zhen
    Wang, Bin-Chao
    Zhou, Qing
    Tu, Hai-Yan
    Wu, Yi-Long
    Yang, Jin-Ji
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
    Santarpia, Mariacarmela
    Massafra, Marco
    Gebbia, Vittorio
    D'Aquino, Antonio
    Garipoli, Claudia
    Altavilla, Giuseppe
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1536 - +
  • [9] MET immunochemistry: a reliable screening tool for MET exon 14 skipping mutations in non -small cell lung cancer?
    Pruis, Melinda A.
    von der Thusen, Jan H.
    Dubbink, Hendrikus Jan
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [10] Soluble c-Met Levels Correlated With Tissue c-Met Protein Expression in Patients With Advanced Non-Small-Cell Lung Cancer
    Gao, Hong-Fei
    Li, An-Na
    Yang, Jin-Ji
    Chen, Zhi-Hong
    Xie, Zhi
    Zhang, Xu-Chao
    Su, Jian
    Lou, Na-Na
    Yan, Hong-Hong
    Han, Jie-Fei
    Wu, Yi-Long
    CLINICAL LUNG CANCER, 2017, 18 (01) : 85 - 91
12345